Murine Efficacy/PD Models
- Syngeneic models, showcasing our ever expanding syngeneic collection, FACS analysis, and checkpoint inhibitor benchmarking
- MuScreen™ CrownBio’s large-scale, staggered screening platform to fast-track the in vivo screening of immunotherapy compounds
- MuPrime™ - allografts of spontaneous murine tumors (from GEMM/carcinogen-induced models), studied in mice with complete immunocompetency
- MuPrime mBR6004 which takes a closer look at our most highly studied MuPrime model including gene expression, immunohistochemistry, treatment data, and immune cell tumor infiltration analysis
